← Back to InvestProbability.com

VKTX Options Probabilities

Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective a...

Trailing P/E
N/A
Market Cap
$3.15872 B

Quantitative Forward Outlook

The current probability surface calculates a 10-Day Densest High ceiling of $50 and a Densest Low floor of $0.

Unlock VKTX 200-Day Probability Cloud ($4/mo)

Related Investment Themes